Barclays lowered the firm’s price target on W. R. Berkley (WRB) to $62 from $64 and keeps an Underweight rating on the shares. The firm adjusted targets in the insurance group as part of a Q1 preview. Premium growth and broker organic growth “are likely to remain sluggish,” the analyst tells investors in a research note. However, Barclays sees solid margins and strong capital deployment still contributing to reported book value growth in Q1.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WRB:
- W. R. Berkley price target lowered to $72 from $73 at Morgan Stanley
- W. R. Berkley price target lowered to $66 from $74 at Keefe Bruyette
- Arm upgraded, Mondelez downgraded: Wall Street’s top analyst calls
- W. R. Berkley resumed at Neutral from Buy at Brean Capital
- W. R. Berkley downgraded to Neutral from Buy at Brean Capital